OM Pharma Ltd. news
OM Pharma is pleased to announce that Etienne Jornod, its Executive Chairman and co-owner, has been recognised as winner of the Swiss Biotech Success Stories Awards 2022.
The awards, bestowed annually by the Swiss Biotech Association, celebrates those who have made important and sustainable contributions to the biotech industry in Switzerland.
The Swiss entrepreneur was particularly distinguished for his scientific and commercial achievements and his lasting contribution
The award will be presented this evening by the Geneva Chamber of Commerce, Industry and Services (CCIG), the State of Geneva, the Office for the Promotion of Industries and Technologies (OPI) and the Office for the Promotion of Equality and Prevention of Violence (BPEV), during a ceremony at the ‘Bâtiment des Forces Motrices’ in Geneva.
The Geneva Economy and Innovation Awards, created in 2012, aim to h
OM Pharma enters into a strategic collaboration agreement granting AstraZeneca the exclusive right to import and distribute the immunological therapy Broncho-Vaxom® for the prevention and treatment of respiratory tract infections in China (excluding Hong Kong, Macau, and Taiwan).
OM Pharma and AstraZeneca celebrated their strategic collaboration agreement today at a partnership signing ceremony in Shanghai.
The strategic collaboration agreement grants AstraZeneca
- Full commitment of Optimus Holding and its shareholders to the sustainable growth of OM Pharma
- More than CHF 250 million investment in R&D and other projects planned
- Expansion of manufacturing capacities in Meyrin/Geneva already decided
Today, Optimus Holding announced the successful closing of the acquisition of OM Pharma, a global biotech company headquartered in Meyrin, Geneva. The new